Titan Medical today provided a progress update regarding its planned merger with surgical guidance technology company Conavi Medical.
The companies entered into a definitive amalgamation agreement to combine in an all-stock transaction last month. They aim to commercialize Conavi’s Novasight Hybrid system for guiding common minimally invasive coronary procedures.
Conavi Medical designs, manufactures and markets imaging technologies for guiding minimally invasive cardiovascular procedures. Novasight Hybrid combines both intravascular ultrasound (IVUS) and optical coherence tomography (OCT) to enable simultaneous and co-registered imaging of coronary arteries.
Novasight Hybrid has FDA 510(k) clearance and regulatory nods in other geographies like Canada, China and Japan. With Titan Medical, Conavi expects the combined company to become a commercial-stage leader in hybrid intravascular imaging.
According to a news release, Titan and Conavi continue t…